Outlooks on Epstein-Barr virus associated gastric cancer

M Naseem, A Barzi, C Brezden-Masley, A Puccini… - Cancer treatment …, 2018 - Elsevier
Epstein-Barr virus associated gastric cancer (EBVaGC) comprises approximately 10% of
gastric carcinomas. Multiple factors contribute to tumorigenesis, including EBV driven …

Medical management of gastric cancer: a 2017 update

N Charalampakis, P Economopoulou… - Cancer …, 2018 - Wiley Online Library
Gastric cancer remains a considerable health burden throughout the world. The Cancer
Genome Atlas (TCGA) analysis has recently unveiled 4 genotypes of gastric cancer with …

Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response

F Zhang, W Wang, Y Long, H Liu, J Cheng, L Guo… - Cancer …, 2018 - Springer
Background Patient-derived organoids and xenografts (PDXs) have emerged as powerful
models in functional diagnostics with high predictive power for anticancer drug response …

Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop

K Lei, X Liang, Y Gao, B Xu, Y Xu, Y Li, Y Tao… - Biochemical and …, 2017 - Elsevier
The long noncoding RNA (lncRNA) ATB is an important regulator in human tumors. Here,
we aimed to investigate the potential molecular mechanisms of lnc-ATB in gastric cancer …

Non-coding RNAs and resistance to anticancer drugs in gastrointestinal tumors

JC Hahne, N Valeri - Frontiers in oncology, 2018 - frontiersin.org
Non-coding RNAs are important regulators of gene expression and transcription. It is well
established that impaired non-coding RNA expression especially the one of long non …

Parameters for predicting surgical outcomes for gastric cancer patients: simple is better than complex

A Guner, SY Kim, JE Yu, IK Min, YH Roh, C Roh… - Annals of surgical …, 2018 - Springer
Background Various parameters are used to predict perioperative surgical outcomes.
However, no comprehensive studies in gastrectomy have been conducted. This study aimed …

Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy

X Dong, Y Wang, Y Zhou, J Wen, S Wang… - Cell death discovery, 2016 - nature.com
Cisplatin (cDDP) remains one of the first-line chemotherapeutic agents for gastric cancer
(GC) treatment, and resistance to cDDP is the major limitation in its clinical application …

KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer

X Dai, Y Chen, N Chen, J Dou, H Zhuang… - …, 2023 - Taylor & Francis
Background Resistance to chemotherapeutic drugs limits the control of gastric cancer (GC)
development. The study intended to probe into the mechanism of aquaporin 3 (AQP3) on the …

Aquaporin-1 facilitates proliferation and invasion of gastric cancer cells via GRB7-mediated ERK and Ras activation

Z Wang, Y Wang, Y He, N Zhang… - Animal Cells and …, 2020 - Taylor & Francis
Gastric cancer, one of the most common malignant tumors of the digestive tract, is devoid of
effective treatment owing to its highly invasive ability. Aquaporins (AQPs), transmembrane …

Osteoporosis and fracture after gastrectomy for stomach cancer: A nationwide claims study

GH Seo, HY Kang, EK Choe - Medicine, 2018 - journals.lww.com
Osteoporosis and fracture after gastrectomy for stomach canc... : Medicine Osteoporosis and
fracture after gastrectomy for stomach cancer: A nationwide claims study : Medicine Log in or …